<DOC>
	<DOCNO>NCT02548754</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) common cardiac arrhythmia . In previous experimental study , investigator find low-level vagus nerve ( VN ) stimulation ( LLVNS ) , voltages substantially slow sinus rate , significantly suppress AF inducibility decrease AF duration . The investigator subsequently develop non-invasive neuromodulatory therapy , LLVNS deliver auricular branch VN locate tragus , anterior protuberance outer canine ear ( low level tragus stimulation ; LLTS ) . The anti-arrhythmic effect LLTS similar LLVNS deliver cervical VN trunk . More recently , proof-of-concept study human , investigator show patient drug-refractory AF undergo AF ablation , LLTS one hour significantly shorten AF duration decrease inflammatory cytokine . The overall objective proposal translate ambulatory patient paroxysmal AF result previous study show acute suppression AF inflammation anesthetize canine well human , order examine long-term therapeutic effect approach . The investigator hypothesize intermittent ( 1 hour daily ) LLTS 6 month may result long-term decrease AF burden suppression inflammatory cytokine patient paroxysmal AF . Patients randomize either active sham LLTS . LLTS deliver transcutaneous electrical nerve stimulation ( TENS ) device 1 hour daily 6-month period . AF burden define percent time spend AF 2-week period , assess noninvasive continuous ECG monitoring baseline 6 month . In addition , blood sample collect patient baseline , 3 6 month , cytokine measurement . These investigation establish first evidence long-term effect LLTS AF suppression patient paroxysmal AF may provide basis potential expansion therapeutic target treatment modality beyond AF .</brief_summary>
	<brief_title>Transcutaneous Electrical Vagus Nerve Stimulation Suppress Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Male female patient older 21 year old 2 . Paroxysmal AF 1 . Left ventricular dysfunction ( Left ventricular ejection fraction &lt; 40 % ) 2 . Significant valvular disorder ( i.e. , prosthetic valve hemodynamically relevant valvular disease ) 3 . Recent ( &lt; 6 month ) stroke myocardial infarction 4 . Severe heart failure ( NYHA IV ) 5 . Left atrial dilatation ( &gt; 55mm ) 6 . Recurrent vasovagal syncopal episodes 7 . Unilateral bilateral vagotomy 8 . Pregnancy breast feed 9 . Sick sinus syndrome , 2nd 3rd degree AV block , bifascicular block prolong ( PR &gt; 300ms ) 1st degree AV block .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>neuromodulation</keyword>
	<keyword>inflammation</keyword>
</DOC>